CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Fabrice Chouraqui

Chief Executive Officer, Pharming Group

Search every verified Fabrice Chouraqui interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Fabrice Chouraqui, who became CEO of Pharming Group in March 2024, discussed the company's history and strategy in an October 2025 podcast. He described Pharming as "uniquely positioned" because it generates revenue from two marketed drugs and does not require new capital annually. Chouraqui stated that the company has a "duty towards our shareholders" and employees to use that cash appropriately. He noted that Pharming has grown from a protein therapy-focused biotech into a multi-asset company with a market cap of at least €800 million, and that it continues to develop its pipeline, including a phase two registrational trial for a drug candidate with a data readout expected at the end of 2027. Chouraqui also reflected on changes in the industry, saying that "science is becoming more complex, the environment is becoming more ambiguous and uncertain, and the pace is ever faster." He added that in this context, "you can no longer think that you own the truth" and that it is important to "make decision fast" even without complete information. In a separate 2023 interview while CEO of Cellarity, a Flagship Pioneering company, Chouraqui discussed the use of AI in drug discovery, arguing that many companies remain "hostage of this reductionist" approach to targeting single molecules, whereas Cellarity aims to address cellular dysfunction.

Recent appearances

  • Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43

    October 22, 2025 · 📺 FlotBio x Philip Hemme

    We travel to the offices of Pharming Group in Leiden, the Netherlands, to chat with the newcomer CEO Fabrice Chouraqui. Fabrice discusses the fascinating history of Pharming, with its first commercial drug RUCONEST produced in the milk of transgenic rabbits. He also talks about the growth of Pharming from a protein therapy-focused biotech into a European multi-asset heavyweight, with a market cap of at least €800 million. ⭐️ ABOUT THE SPEAKER Fabrice Chouraqui has been the CEO of Pharming Group since March 2024. Prior to this, he was a CEO-Partner at the US biotech venture capital firm Fla…

    Watch on YouTube ↗

  • 2023 Flagship CEO Chat: Fabrice Chouraqui, CEO of Cellarity

    January 12, 2023 · 📺 Flagship Pioneering

    Fabrice Chouraqui, CEO of Cellarity & Flagship Pioneering CEO-Partner, sits down with Christine Heenan, Chief Communications Officer & Executive Partner, Flagship Pioneering @ JPM 2023. For more on Cellarity, visit https://cellarity.com/. Website: www.flagshipioneering.com Twitter: @FlagshipPioneer Linkedin:   / flagship-pioneering  

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →